(MedPage Today) — At least a dozen Miami-area patients developed serious eye infections after receiving ocular injections of bevacizumab (Avastin) for “wet” macular degeneration, the FDA said.
Month: August 2011
Eye Problems From Repackaged Bevacizumab
Some patients treated with repackaged bevacizumab for neovascular age-related macular degeneration have developed eye infections, and some have gone blind, the FDA warned today. Medscape Medical News
Eye Disease Linked To Common Soil Fungus Found In The U.S.
Histoplasmosis is a fungal infection that enters the body through the lungs, and individuals living in Ohio River Valley have probably heard about it. Usually connected with pulmonary disease, if left untreated histoplasmosis can also lead to loss of v…
Avastin/Lucentis Update 48: Contaminated Re-Packaged Avastin Causes Severe Eye Problems
The inevitable was bound to happen. A pharmacy in Hollywood, FL repackaged Avastin into single-use syringes and in the process contaminated the drug that was then sold to several clinics for the treatment of wet AMD, causing severe eye damage, includin…
How This Blog Has Developed…into a Business!
I started this blog 2.5 years ago. We have started a medical marketing company to teach other docs to do the same!
IRIDEX introduces new XP Module for IQ 532 ENT laser system
IRIDEX Corporation announced the introduction of its new XP Module – a high power factory installed option for the IRIDEX IQ 532 green laser system.
FDA Approves Multicolor Pattern Scan Laser for Eye Surgery
A new scan laser photocoagulator allows eye surgeons to choose 1 or more of 3 popular laser colors. Medscape Medical News
Correcting Peripheral Vision May Help Slow Progression Of Myopia
New scientific evidence on how feedback from the eye affects visual development may lead to more effective approaches to treating myopia (nearsightedness) in children, reports a paper in the September issue of Optometry and Vision Science, official jou…
Genetic Link To Mesothelioma Discovered
Scientists have found that individuals who carry a mutation in a gene called BAP1 are susceptible to developing two forms of cancer mesothelioma, and melanoma of the eye. Additionally, when these individuals are exposed to asbestos or similar mineral …
NIDEK Gets FDA Clearance for a New Multicolor Pattern Scan Laser Photocoagulator
The MC-500 Vixi by NIDEK is a photocoagulator with customizable use of one, two or three different wavelengths. The operator can choose the best color or combination of colors for treatment of varying ocular pathology. The device supports the mostly used colors 532 nm Green, 577 nm Yellow, or 647 nm Red . To get the best results you can choose your (Read more...)
Eyeborg Project Leader Looks at the Future of Prosthetics and Implants
The Eyeborg Project, a collaboration between Rob Spence, a filmmaker who lost his right eye in an accident, and Kosta Grammatis, an unemployed engineer, combines biomedical engineering and art in a device that not only seeks to revolutionize ocular prostheses, but also will record the world in a perspective never seen before. The Eyeborg is a prost (Read more...)
Similar Uveitis Outcomes With Local Vs Systemic Steroids
Systemic and local corticosteroid therapies work equally well for preserving and improving sight in patients with the most vision-threatening forms of uveitis, a new randomized trial demonstrates. Reuters Health Information
Shopping in Scrubs: OK or Not? Physicians Are Talking
In this discussion, physicians get heated up over whether it’s OK to wear scrubs outside the hospital. What side are you on? Medscape Family Medicine
Four Tiny Tactics That Bring in Big Money
Some ways to bring in more income are difficult or extensive, but a few small overlooked tactics can create a significant bottom-line increase. Medscape Business of Medicine
‘Doctor, I’m Sure You Didn’t Tell Me About Those Risks!’
It’s often difficult to have an adequate informed consent discussion. Plus, a patient’s recollection of the conversation may differ from yours. Here’s a way to reduce the risk. Medscape Business of Medicine
VEGF Trap Denied by FDA
VEGF Trap Eye is another anti-VEGF medication to be injected into the eye for the treatment of wet macular degeneration. The FDA did not approve recently, but will reconsider by November!
Visual Benefits Of Anti-VEGF Therapy May Diminish Upon Extended Dosing
Long-term outcomes of anti-VEGF therapy for neovascular age-related macular degeneration suggest that eyes with good visual acuities require long-term regular dosing, according to a presentation here.
Visual Benefits Of Anti-VEGF Therapy May Diminish Upon Extended Dosing
Long-term outcomes of anti-VEGF therapy for neovascular age-related macular degeneration suggest that eyes with good visual acuities require long-term regular dosing, according to a presentation here.
KalVista raises £8 million in series A round of funding
KalVista Pharmaceuticals, a new ophthalmology company with a focus on diabetic macular edema (DME), has raised £8 million in a series A round from leading life sciences investors Novo A/S and SV Life Sciences.
Kellogg Researcher Helping Eye Care Providers Better Assess Driving In Older Adults
Drivers over age 65 are the fastest-growing segment of the driving population, and their eye care providers ophthalmologists and optometrists are playing an increasingly important role in assessing their ability to drive safely. Kellogg researcher Davi…